228 related articles for article (PubMed ID: 12490619)
1. Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide.
Zhao K; Luo G; Zhao GM; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Jan; 304(1):425-32. PubMed ID: 12490619
[TBL] [Abstract][Full Text] [Related]
2. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent dyes alter intracellular targeting and function of cell-penetrating tetrapeptides.
Szeto HH; Schiller PW; Zhao K; Luo G
FASEB J; 2005 Jan; 19(1):118-20. PubMed ID: 15489247
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA.
Shimoyama M; Shimoyama N; Zhao GM; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2001 Apr; 297(1):364-71. PubMed ID: 11259564
[TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacokinetics of selective mu-opioid peptide agonists.
Szeto HH; Lovelace JL; Fridland G; Soong Y; Fasolo J; Wu D; Desiderio DM; Schiller PW
J Pharmacol Exp Ther; 2001 Jul; 298(1):57-61. PubMed ID: 11408525
[TBL] [Abstract][Full Text] [Related]
7. Dansylated analogues of the opioid peptide [Dmt1]DALDA: in vitro activity profiles and fluorescence parameters.
Berezowska I; Lemieux C; Chung NN; Zelent B; Schiller PW
Acta Biochim Pol; 2004; 51(1):107-13. PubMed ID: 15094830
[TBL] [Abstract][Full Text] [Related]
8. Type and location of fluorescent probes incorporated into the potent mu-opioid peptide [Dmt]DALDA affect potency, receptor selectivity and intrinsic efficacy.
Schiller PW; Berezowska I; Weltrowska G; Chen H; Lemieux C; Chung NN
J Pept Res; 2005 Jun; 65(6):556-63. PubMed ID: 15885115
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and bioactivity of monobiotinylated DALDA: a mu-specific opioid peptide designed for targeted brain delivery.
Bickel U; Yamada S; Pardridge WM
J Pharmacol Exp Ther; 1994 Feb; 268(2):791-6. PubMed ID: 8113991
[TBL] [Abstract][Full Text] [Related]
10. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
11. An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2.
Gonzalez DE; Covitz KM; Sadée W; Mrsny RJ
Cancer Res; 1998 Feb; 58(3):519-25. PubMed ID: 9458100
[TBL] [Abstract][Full Text] [Related]
12. Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells.
Wenzel U; Gebert I; Weintraut H; Weber WM; Clauss W; Daniel H
J Pharmacol Exp Ther; 1996 May; 277(2):831-9. PubMed ID: 8627565
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures.
Shu C; Shen H; Hopfer U; Smith DE
Drug Metab Dispos; 2001 Oct; 29(10):1307-15. PubMed ID: 11560874
[TBL] [Abstract][Full Text] [Related]
14. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
15. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.
Ganapathy ME; Huang W; Wang H; Ganapathy V; Leibach FH
Biochem Biophys Res Commun; 1998 May; 246(2):470-5. PubMed ID: 9610386
[TBL] [Abstract][Full Text] [Related]
16. Highly potent fluorescent analogues of the opioid peptide [Dmt1] DALDA.
Berezowska I; Chung NN; Lemieux C; Zelent B; Szeto HH; Schiller PW
Peptides; 2003 Aug; 24(8):1195-200. PubMed ID: 14612191
[TBL] [Abstract][Full Text] [Related]
17. In vivo disposition of dermorphin analog (DALDA) in nonpregnant and pregnant sheep.
Szeto HH; Clapp JF; Desiderio DM; Schiller PW; Grigoriants OO; Soong Y; Wu D; Olariu N; Tseng JL; Becklin R
J Pharmacol Exp Ther; 1998 Jan; 284(1):61-5. PubMed ID: 9435161
[TBL] [Abstract][Full Text] [Related]
18. Phe-Gly dipeptidomimetics designed for the di-/tripeptide transporters PEPT1 and PEPT2: synthesis and biological investigations.
Våbenø J; Lejon T; Nielsen CU; Steffansen B; Chen W; Ouyang H; Borchardt RT; Luthman K
J Med Chem; 2004 Feb; 47(4):1060-9. PubMed ID: 14761208
[TBL] [Abstract][Full Text] [Related]
19. Quantification of [Dmt1]DALDA in ovine plasma by on-line liquid chromatography/quadrupole time-of-flight mass spectrometry.
Wan H; Desiderio DM
Rapid Commun Mass Spectrom; 2003; 17(6):538-46. PubMed ID: 12621615
[TBL] [Abstract][Full Text] [Related]
20. Beta- and gamma-di- and tripeptides as potential substrates for the oligopeptide transporter hPepT1.
Hubatsch I; Arvidsson PI; Seebach D; Luthman K; Artursson P
J Med Chem; 2007 Oct; 50(21):5238-42. PubMed ID: 17887660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]